Long-Term Follow-Up of Ibrutinib Monotherapy in Symptomatic, Previously Treated Patients With Waldenstrom Macroglobulinemia

Steven P. Treon, MD, PhD; Kirsten Meid, MPH; Joshua Gustine, MPH; Guang Yang, MD; Lian Xu, BS; Xia Liu, MD; Christopher J. Patterson, MAcc, MPH; Zachary R. Hunter, PhD; Andrew R. Branagan, MD, PhD; Jacob P. Laubach, MD; Irene M. Ghobrial, MD; M. Lia Palomba, MD; Ranjana Advani, MD; and Jorge J. Castillo, MD

Long-Term Follow-Up of Ibrutinib Monotherapy in Symptomatic, Previously Treated Patients With Waldenstrom Macroglobulinemia

J Clin Oncol 39:565-575 Accepted on August 14, 2020 and published at ascopubs.org/journal/jco on September 15, 2020: DOI https://doi.org/10.1200/JCO.20.00555